Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @KymeraTx
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @KymeraTx
-
Check out this
@statnews story on targeted protein degradation: a powerful and practical new approach to address inflammation, the underlying driver of many hard-to-treat diseases.#NewWayNewRules#drugdiscovery http://bit.ly/31r20Xz pic.twitter.com/TDvk90Klwf
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our team is in Greece this week to present preclinical data for our IRAK4 degrader program at the 9th Conference of the European Hidradenitis Suppurativa Foundation. Learn more about our findings. http://bit.ly/2So1OEj pic.twitter.com/Olca6UvFLk
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today Kymera shared preclinical data showing our oral protein degraders completely suppress IRAK4 expression in skin and immune cells and inhibit cutaneous inflammation. And we named
#HS as our first inflammation/immunology disease indication! http://bit.ly/2So1OEj pic.twitter.com/w3iQsI9yvZ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're heading to San Diego for the warmer weather and the North American Protein Degradation Congress! Chris De Savi, PhD, will present on the promise of targeted protein degradation and the development of our first-in-class IRAK4 protein degraders.pic.twitter.com/sryQbnK7Gh
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Stop by and learn how we are advancing our STAT3 degraders into the clinic & expanding the biological impact of STAT3 degradation in liquid and solid tumors. http://ow.ly/ihob50y2iVh pic.twitter.com/qhhKbPUXP3
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our proprietary technology platform, Pegasus, advances our understanding of the partnering of E3 ligases and targets in order to optimize target degradation. Learn more: http://kymeratx.com/platform/pegasus/ …pic.twitter.com/kwm7hhUkKQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kymera Therapeutics proslijedio/la je Tweet
Excited for the 3rd official
@Kymera JPM. Big plans for us this year on both science and business. So honored to represent with Jared (CMO) and Bruce (CFO) our amazing team in the next few days. Connect with us in SF.pic.twitter.com/2W05DmtBo6
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We’re hiring! Learn more about the Group Leader, Platform Biology role and our other openings: http://kymeratx.com/careers/ pic.twitter.com/FK0pGm45YA
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Happy New Year! In 2020, we'll continue to pioneer
#targetedproteindegradation and define the parameters that can transform the ubiquitin proteasome system into a small molecule-directed protein degradation therapeutic platform with applications across most, if not all, diseases.pic.twitter.com/lMPpWxJ1na
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our team celebrated many great milestones this year and we're excited for our next chapter in 2020! Have a happy holiday season from all of us at Kymera!pic.twitter.com/cDerjoCFnk
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're hiring a Project Lead in Immunology! Serve as a leader and
#drugdiscovery architect at a growing biotech company. Define and implement strategy to deliver meaningful medicines to patients with limited or no options. Learn more about the role: http://kymeratx.com/careers/project-leader-immunology-associate-director-to-director/ …pic.twitter.com/ZZzQBFKZFX
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Celebrating a key milestone at the Kymera office!pic.twitter.com/Xe7UDdH8S3
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
“These data highlight the potential for STAT3 degraders to treat STAT3-dependent lymphomas and leukemias," says Dr. Jared Gollob, our CMO. Read more about our
#ASH19 Presentation and latest data package:https://www.kymeratx.com/press_releases/kymera-therapeutics-to-present-preclinical-data-demonstrating-potent-antitumor-activity-by-a-selective-stat3-degrader-in-hematologic-malignancies-at-the-american-society-of-hematology-annual-meeting/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The
@Kymeratx team is heading to Orlando! We'll be presenting a poster at#ASH19 on Monday, December 9th at 6:00pm EST. We hope to see you there!pic.twitter.com/VeQqSQ8RWh
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kymera's Pegasus platform is a powerful
#drugdiscovery engine discovering novel protein degraders that target and disrupt protein complexes and full signaling cascades, placing once elusive disease pathways within our reach. Learn more: http://kymeratx.com/platform/pegasus/ …pic.twitter.com/TekFPE0SQd
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
"We have enough examples out there that we can make these molecules look like drugs or act like drugs. People feel now is really the time to double down."
@NelloMainolfi, our CEO, in@cenmag's "Year in Pharma 2019":https://cen.acs.org/content/cen/articles/97/i47/CENs-Year-in-Pharma-2019.html …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Wishing everyone a Happy Thanksgiving from the Kymera team!pic.twitter.com/h2izyoJDKT
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We have an exciting line up of presentations in Dec! Next week, we'll be sharing our story at the 31st Annual @PiperJaffrayCo Healthcare Conference and the Evercore ISI 2nd Annual HealthCONx Conference.
@NelloMainolfi will present on our innovative technology & pipeline progress.pic.twitter.com/3OQjITPBV1
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kymera Therapeutics proslijedio/la je Tweet
Thrilled to have
@NelloMainolfi step into the CEO role at@KymeraTx! Looking forward to great things under his continued and now expanded leadership!https://www.kymeratx.com/press_releases/kymera-therapeutics-promotes-nello-mainolfi-phd-to-chief-executive-officer/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're thrilled to announce
@NelloMainolfi has been appointed as Kymera's Chief Executive Officer! Read more about this exciting milestone:http://kymeratx.com/press_releases/kymera-therapeutics-promotes-nello-mainolfi-phd-to-chief-executive-officer/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.